Non-invasive Brain Tumor Molecular Diagnostics and Monitoring

Recruiting Observational Study
Brain Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
The Institute of Molecular and Translational Medicine, Czech Republic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This prospective multicenter study aims to enroll GBM patients who will undergo repeated assessments (preoperatively and 3 months post-surgery) to detect circulating tumor cells and analyze the transcriptomic profiles of EVs in their blood. The prognostic and monitoring significance of these biomarkers to disease course (assessing treatment efficacy, resistance incidence, tumor progression) will b…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Adult patients with brain tumors - Exclusion Criteria: No other cancer; no inflammatory disease \-
Contacts

Josef Srovnal, MD,PhD

+420585632137

josef.srovnal@upol.cz

CONTACT

Ondrej Kalita, MD,PhD

+420588443568

ondrej.kalita@fnol.cz

CONTACT